Paul T. Quinlan, General Counsel at Oruka Therapeutics, Inc. (ORKA), sold 733 shares at $69.69 ($51K) on 2026-06-15, disclosed to the SEC on 2026-06-15.
Open-market sale of $51k ORKA by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORKA | SELL | 2026-08-14 | $5.6M | — | Filing → |
| ORKA | SELL | 2026-03-17 | $30K | — | Filing → |
| CBAY | SELL | 2024-01-16 | $236K | — | Filing → |